What is polivy's typical age range in clinical trials?

Polivy (polatuzumab vedotin) has been studied in adults only. The typical age range in clinical trials is 18 years and older, with no pediatric data supporting use. Trials generally include older adults as well (median ages often around 60–65 years), but the exact min/max ages vary by study.

If you want, I can look up the precise age inclusion criteria for a specific Polivy trial (e.g., GO29365 or POLARIX) to give you the exact numbers.